- Our products
- Ocular Health Section
- Research & Innovation
- Fondation Théa
Listen to Jean-Frédéric's "fireside chat" recorded during the OIS meeting with Joseph Sullivan, Founder of Emmetropes, to discover:
● Théa's objectives for the next few years in both existing and new markets.
● The progress of Théa Open Innovation that has made implementing licensing agreements and capital investments with early stage partners. The subsidiary has already signed agreements that help advance treatments for myopia, wet and dry age-related macular degeneration and macular edema.
● How Théa became a leader in Europe and how it plans to continue to use its business formula to tap into the U.S. market.